Cite Filings / ORKA / 0001950047-26-011386
Feed Companies Filings Check
Sign in
144

Sale of Securities

Oruka Therapeutics, Inc. · Filed 2026-11-20 · Acc 0001950047-26-011386

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-11-20 144 Sale of Securities
  • 2026-11-20 4 General Counsel sold 9,000 shares at an average $94.89 ($853,986)
  • 2026-11-16 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-11-16 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-11-16 4 Chief Medical Officer sold 7,000 shares at an average $100.96 ($706,700)
  • 2026-11-13 4 Senior Vice President, Finance sold 10,000 shares at an average $104.97 ($1,049,658)
  • 2026-11-12 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…